Frovatriptan
Sponsors
Thomas Jefferson University, Endo Pharmaceuticals, Scott and White Hospital & Clinic, SK Chemicals Co., Ltd., Clinvest
Conditions
Analgesic Overuse HeadacheBleedingMedication Overuse HeadacheMenstrual Migraine (MM) HeadachesMenstrually Associated MigraineMigraineMigrainesSpotting
Phase 2
Phase 3
A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual Migraine
CompletedNCT00644033
Start: 2001-06-30End: 2002-06-30Updated: 2024-01-02
A Double Blind Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Frovatriptan in the Acute Treatment of Migraine
CompletedNCT00821483
Start: 2006-11-30End: 2008-02-29Updated: 2013-04-18
Phase 4
Pilot Study to Compare Frovatriptan vs. Topiramate for Prevention of Migraine
CompletedNCT00846495
Start: 2009-08-31End: 2011-01-31Updated: 2012-01-13
Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment) Of Menstrual Migraine
CompletedNCT00904098
Start: 2005-09-30End: 2006-02-28Updated: 2010-02-15
Unknown Phase
A Research Study To Evaluate If Frovatriptan Is Safe And Effective In Preventing Migraine Headache After Fasting
CompletedNCT00440232
Start: 2007-07-31End: 2009-09-30Updated: 2011-05-26
Prevention of Menstrual Migraines: Using Frovatriptan or Placebo During Hormone Free Intervals
CompletedNCT00700128
Start: 2008-06-30End: 2010-01-31Updated: 2011-07-25